Correction to: Pharmacological Reports 70 (2018) 446–454 https://doi.org/10.1016/j.pharep.2017.11.008
In Fig. 2 of this article should have appeared as shown below.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
do D. Rodrigues, M., Santiago, P.B.G.S., Marques, K.M.R. et al. Correction to: Selective cytotoxic and genotoxic activities of 5-(2-bromo-5- methoxybenzylidene)-thiazolidine-2,4-dione against NCI-H292 human lung carcinoma cells. Pharmacol. Rep 74, 1115 (2022). https://doi.org/10.1007/s43440-022-00376-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s43440-022-00376-x